RxDoctor Payments DataLook up a doctor →

Antoinette Pragalos, MD

Internal Medicine · Cincinnati, OHNPI 1851393730

Payments from drug & device makers

$27,790,473in general payments, 2019–2025

Across 3,036 payments — averaging $9153.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$12.2M
  • Modernatx, Inc.$8.6M
  • Pfizer$2M
  • Biontech SE$1.6M
  • Bavarian Nordic A/s$941K
  • Merck$892K
  • plus $1.5M from 6 others

General payments by program year

20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Janssen Research & Development, LLC244$12,169,067
Modernatx, Inc.1,853$8,608,814
Pfizer185$2,015,810
Biontech SE170$1,617,319
Bavarian Nordic A/s62$941,068
Merck6$891,980
GSK34$791,346
Seqirus USA Inc421$573,996
Vanda Pharmaceuticals Inc.34$100,786
AstraZeneca2$41,981
AbbVie24$38,292
Novo Nordisk1$16

How this compares

$27,790,473 in reported general payments places this provider in the 95th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$55,582
Medicare patients
285
Services billed
1,343

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →